ZHONGHUA YANGSHENG BAOJIAN ›› 2023, Vol. 41 ›› Issue (19): 4-7.

Previous Articles     Next Articles

Comparison of the Therapeutic Effect of Transurethral Holmium Laser Enucleation in Patients with BPH after Transrectal or Transperineal Prostate Biopsy

WANG Xuan-feng1,2, WANG Xiong3, GE Qing-yu1, TAO Tao2,*   

  1. 1. Department of Urology, Chuzhou Hospital of Combined Traditional Chinese and Western Medicine, Anhui University of Traditional Chinese Medicine, Chuzhou Anhui 239000, China;
    2. Department of Urology, The First Hospital Affiliated to the University of Science and Technology of China (Anhui Provincial Hospital), Hefei Anhui 230001, China;
    3. Graduate School of Wannan Medical College, Wuhu Anhui 241000, China
  • Online:2023-10-01 Published:2023-09-20

Abstract: Objective To observe and analyze the safety and effectiveness of transurethral holmium laser enucleation of the prostate (HoLEP) in patients with BPH after transrectal or transperineal prostate biopsy. Methods The data of 60 BPH patients who underwent HoLEP in the Department of Urology, First Affiliated Hospital of USTC(Anhui Provincial Hospital) from January 2018 to June 2020 were collected. All the patients are diagnosed by prostate biopsy and divided into transperineal group and transrectal group according to the operational approach.There were 29 cases in the transperineal group and 31 cases in the transrectal group. The basic information, perioperative indicators and follow-up data of 3 and 6 months after surgery were collected and analyzed. Results The length of surgery and postoperative catheterization time in the transrectal group was longer than that in the transperineal group, and the difference was statistically significant (P<0.05). The overall postoperative complication rate was lower in the transperineal group than in the transrectal groupthe transperineal group, the difference between the two groups was statistically significant (P<0.05). Comparison of the International Prostate Symptom Score (IPSS), Quality of Life Score (QOL) for prostate symptoms and maximal urinary flow rate (Qmax) of patients in the two groups at 3 and 6 months postoperatively, the difference was not statistically significant (P>0.05). Conclusion HoLEP treatment for BPH patients at 3 weeks after transperineal or transrectal prostate biopsy is effective and safe. In the patients who underwent HoLEP after transperineal biopsy, the operation time and indwelling catheterization time are shorter and has fewer complications postoperatively.

Key words: benign prostatic hyperplasia, transrectal prostate biopsy, transperineal prostate biopsy, transurethral holmium laser enucleation of the prostate

CLC Number: